PGAC logo

PANTAGES CAPITAL ACQUISITION

PGACNASDAQ
πŸ† #3565 by market capUS Equity
$606.46β–² $14.74 (+2.43%)
Simulated price
1hβ€”
24hβ–² 2.4%
7dβ–² 5681.3%
14dβ–² 5681.3%
30dβ–² 5681.3%
1yβ–² 5869.1%
🏦Market Cap
$32M
Small Cap
πŸ“ˆRevenue Growth (YoY)
β€”
πŸ“ŠGross Margin
β€”
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
β€”
Otter Score
56
Weak

Trading Snapshot

Day Range
$600.18 – $615.97
52-Week Range
$10.20 – $11.39
Volume
$1.89B
Avg Volume
$1.96B
Shares Outstanding
5.1M
Next Earnings
Sep 6, 2026

Fundamentals Snapshot

Annual Revenue
$6M
Last Q Revenue
$2M
P/E Ratio
14.3
P/S Ratio
β€”
EPS (TTM)
$0.20
Dividend Yield
β€”

Why Investors Own PGAC

  • βœ“High-growth profile β€” revenue up +33.0% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 38% gross margin and 10% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$6Mβ–² +30.5% YoY
Gross Margin (TTM)
38.2%β–² +3.3% YoY
Operating Income (TTM)
$648,349β–² +30.5% YoY
Free Cash Flow (TTM)
$583,515β–² +30.5% YoY

About PANTAGES CAPITAL ACQUISITION

Pantages Capital Acquisition Corporation currently lacks significant operational activities. Its principal objective is to pursue and finalize a strategic business combination, which may take the form of a merger, a share exchange, an asset acquisition, a share purchase, a corporate reorganization, or a similar transaction with one or more entities. The company was established in 2024 and is based in Wilmington, Delaware. In August 2025, it rebranded as Pantages Capital Acquisition Corporation, having previously operated under the name Aifeex Nexus Acquisition Corporation.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
56/100

Analyst Price Target

β“˜
Average Target
$752.95
β–² +24.2% Upside
High Target$918.47
Low Target$586.90
Based on 26 analysts

Latest News & Updates